Drug intelligence / Profile preview

Xinfeng capsule

Development stage
Unknown
Lead developer
First Affiliated Hospital of Anhui University of Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Xinfeng capsule is a traditional Chinese medicine (TCM) compound formulation that has been clinically used for over 20 years, primarily in the treatment of rheumatoid arthritis (RA), as well as ankylosing spondylitis and osteoarthritis. The formula typically contains Tripterygium wilfordii (Thunder God Vine), Astragalus root (Radix Astragali Mongolici), and coix seed. Its mechanism of action involves anti-inflammatory and immunomodulatory effects, including inhibition of inflammation and oxidative stress by up-regulating LINC00638 and activating the Nrf2/HO-1 pathway. Network pharmacology studies suggest it targets multiple pathways relevant to RA pathogenesis such as TNF, IL-17, NF-κB signaling, TLR4/MAPK/NF-κB pathway modulation, reduction of proinflammatory cytokines (TNF-α, IL-6, IL-17), improvement in coagulation parameters associated with RA-related hypercoagulable state, promotion of apoptosis in inflammatory cells, and antioxidant activity. Key active components identified include triptolide (from Tripterygium wilfordii), quercetin (from various herbal sources), formononetin (from Astragalus root), β-sitosterol and stigmasterol[2][3][4][5][8]. Clinical studies have shown efficacy in reducing immune inflammation markers such as CRP and ESR in RA patients[1][3].

Brand names
Xinfeng capsuleXFC
Other names
Xinfeng capsuleXFC
02

Targets

HMOX1 (Heme oxygenase 1)IL-17A (Interleukin-17A)IL-6 (Interleukin 6)MAPK14 (p38 mitogen-activated protein kinase alpha)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NF-κBTLR4 (Toll-like receptor 4)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Xinfeng capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinfeng capsule.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call